Katharina G. McFarland, Director at Transphorm, Inc. (TGAN), sold 840 shares at $4.85 ($4K) on 2024-04-24, disclosed to the SEC on 2024-04-26.
Scheduled sale ($4k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TGAN | SELL | 2024-05-24 | $20K | — | Filing → |
| SAIC | SELL | 2024-04-12 | $191K | — | Filing → |
| TGAN | SELL | 2024-03-01 | $19K | — | Filing → |